The Conscious Fund

The Conscious Fund is a venture capital firm specializing in early-stage investments in companies developing psychedelic medicines and therapies. Their mission is to support ventures that aim to improve mental health, address addiction, and manage pain through innovative treatments. The firm operates across multiple jurisdictions, including the United States, the United Kingdom, and Malta, reflecting its international investment approach.

The fund focuses on seed and early-stage investments, typically ranging from $1 million to $5 million. This investment range is designed to support companies that are too large for traditional venture capital firms but too small for boutique investment banks and private equity firms. The Conscious Fund's portfolio includes companies in sectors such as healthcare, biotechnology, pharmaceuticals, mental health, addiction treatment, and pain management.

By concentrating on these areas, The Conscious Fund aims to foster the development of groundbreaking therapies that can significantly enhance patient outcomes and contribute to the broader field of psychedelic medicine. Their strategic approach combines financial support with a commitment to advancing treatments that address complex health challenges, positioning them as a key player in the evolving landscape of psychedelic healthcare solutions.